Table 2.
Facility Characteristics Associated With Carbapenemase Testing for CRE Cultures
| Facility Characteristic | CRE Cultures Tested for CP (n=1,905, 33.0%), No. (%) |
CRE Cultures Not Tested for CP (n=3,873, 67.0%), No. (%) |
P Value |
|---|---|---|---|
| US Census region | |||
| Northeast | 432 (37.2) | 728 (62.8) | <.0001 |
| Midwest | 207 (30.1) | 481 (69.9) | |
| West | 213 (34.3) | 408 (65.7) | |
| South | 659 (34.7) | 1,049 (61.4) | |
| Outside continental United States | 394 (24.6) | 1,207 (75.4) | |
| Rurality | |||
| Rural | 74 (26.9) | 201 (73.1) | .03 |
| Urban | 1,831 (33.3) | 3,672 (66.7) | |
| AMC affiliation | |||
| Yes | 1,884 (33.0) | 3,814 (66.9) | .01 |
| No | 20 (25.0) | 60 (75.0) | |
| Complexity level | |||
| High | 1,808 (33.6) | 3,579 (66.4) | <.0001 |
| Low | 92 (23.5) | 299 (76.5) | |
| Transplant programs | |||
| None | 1,695 (33.9) | 3,302 (66.1) | <.0001 |
| 1–2 in-house programs or 3 sharing programs | 173 (24.5) | 534 (75.5) | |
| 3+ in-house programs | 37 (50.0) | 37 (50.0) |
Note. CRE, carbapenem-resistant Enterobacterales; CP, carbapenemase production; AMC, academic medical center.